HIV genotyping is an important laboratory test that helps identify genetic changes in the human immunodeficiency virus. These changes can influence how the virus responds to antiretroviral medications. By identifying drug resistance mutations, healthcare professionals can make informed decisions about treatment selection and adjustments. Genotyping supports personalized HIV care, helps evaluate treatment challenges.
Antiretroviral therapy (ART) involves using a combination of medications to control HIV replication. Although modern treatments are highly effective, some individuals experience drug resistance, which can make particular medications less effective. HIV genotyping provides information that helps healthcare professionals understand these resistance patterns and select appropriate treatment combinations.
The test generally examines specific regions of the HIV genome associated with resistance to different medication classes. These include reverse transcriptase, protease, and integrase genes. Identifying mutations in these regions helps determine whether the virus may respond to particular antiretroviral drugs.
Important aspects of HIV genotyping include:
Drug resistance identification: Detects genetic mutations associated with reduced susceptibility to specific antiretroviral medications.
Treatment selection: Helps healthcare professionals choose medication combinations based on identified resistance patterns.
Treatment failure assessment: Provides useful information when viral suppression is not achieved or viral load increases during therapy.
Personalized treatment planning: Supports decisions based on an individual's HIV resistance profile.
Resistance monitoring: Helps identify changes that may influence future treatment decisions.
Genotyping is particularly useful when selecting an initial treatment regimen for individuals who may have acquired drug-resistant HIV. It can also provide valuable information when an existing treatment plan needs to be reviewed.
HIV genotyping contributes to antiretroviral therapy by helping healthcare professionals understand which medications are likely to remain effective against a particular viral strain. The results are interpreted alongside clinical history, viral load measurements, previous treatment exposure, and other relevant laboratory findings.
During treatment planning, healthcare professionals examine the mutations identified through genetic testing. Some mutations are associated with resistance to individual medications, while others may influence how effectively an entire drug class works. Certain combinations of mutations can also produce more complex resistance patterns.
The information obtained through genotyping supports several important treatment decisions:
Choosing initial therapy: Helps identify transmitted resistance mutations before starting antiretroviral treatment.
Changing existing medications: Supports the selection of alternative drugs when resistance contributes to treatment failure.
Evaluating medication effectiveness: Helps explain why certain medications may no longer provide adequate viral suppression.
Selecting drug combinations: Supports the development of regimens containing medications that are expected to remain active against the virus.
Reducing ineffective treatment exposure: Helps avoid selecting medications that are unlikely to provide sufficient antiviral activity.
HIV genotyping is commonly considered when viral load remains detectable or increases despite treatment. However, test results must be interpreted carefully because resistance mutations can become less detectable after medications are discontinued. Previous resistance test results and treatment records therefore remain important when evaluating an individual's resistance history.
The test also has limitations. Genotyping may not identify every minority viral population carrying resistance mutations, and some mutations have different effects depending on the presence of other genetic changes. Additionally, the test may be less informative when HIV viral load is very low.
Healthcare professionals may combine genotyping with phenotypic resistance testing when additional information is required. Phenotypic testing evaluates how effectively HIV grows in the presence of different antiretroviral medications, providing another perspective on drug susceptibility.
Together, HIV genotyping, viral load monitoring, and clinical assessment help healthcare professionals make evidence-based decisions about antiretroviral therapy and evaluate treatment effectiveness over time.